CDTX
Price
$21.78
Change
+$0.89 (+4.26%)
Updated
May 1, 04:59 PM (EDT)
Capitalization
272.89M
TTNP
Price
$3.85
Change
+$0.12 (+3.22%)
Updated
May 1, 03:31 PM (EDT)
Capitalization
3.52M
Ad is loading...

CDTX vs TTNP

Header iconCDTX vs TTNP Comparison
Open Charts CDTX vs TTNPBanner chart's image
Cidara Therapeutics
Price$21.78
Change+$0.89 (+4.26%)
Volume$100
Capitalization272.89M
Titan Pharmaceuticals
Price$3.85
Change+$0.12 (+3.22%)
Volume$957
Capitalization3.52M
CDTX vs TTNP Comparison Chart
Loading...
CDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TTNP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CDTX vs. TTNP commentary
May 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CDTX is a Hold and TTNP is a Hold.

Ad is loading...
COMPARISON
Comparison
May 02, 2025
Stock price -- (CDTX: $21.05 vs. TTNP: $3.73)
Brand notoriety: CDTX and TTNP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CDTX: 40% vs. TTNP: 2%
Market capitalization -- CDTX: $272.89M vs. TTNP: $3.52M
CDTX [@Biotechnology] is valued at $272.89M. TTNP’s [@Biotechnology] market capitalization is $3.52M. The market cap for tickers in the [@Biotechnology] industry ranges from $293.01B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CDTX’s FA Score shows that 0 FA rating(s) are green whileTTNP’s FA Score has 0 green FA rating(s).

  • CDTX’s FA Score: 0 green, 5 red.
  • TTNP’s FA Score: 0 green, 5 red.
According to our system of comparison, CDTX is a better buy in the long-term than TTNP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CDTX’s TA Score shows that 4 TA indicator(s) are bullish while TTNP’s TA Score has 3 bullish TA indicator(s).

  • CDTX’s TA Score: 4 bullish, 6 bearish.
  • TTNP’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, TTNP is a better buy in the short-term than CDTX.

Price Growth

CDTX (@Biotechnology) experienced а -3.88% price change this week, while TTNP (@Biotechnology) price change was +0.81% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.98%. For the same industry, the average monthly price growth was +8.35%, and the average quarterly price growth was -7.74%.

Reported Earning Dates

CDTX is expected to report earnings on Aug 13, 2024.

TTNP is expected to report earnings on Mar 20, 2025.

Industries' Descriptions

@Biotechnology (+2.98% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CDTX($273M) has a higher market cap than TTNP($3.52M). TTNP YTD gains are higher at: 14.411 vs. CDTX (-21.689). TTNP has higher annual earnings (EBITDA): -7.09M vs. CDTX (-175.87M). CDTX has more cash in the bank: 190M vs. TTNP (4.09M). TTNP has less debt than CDTX: TTNP (0) vs CDTX (3.58M). CDTX has higher revenues than TTNP: CDTX (1.28M) vs TTNP (0).
CDTXTTNPCDTX / TTNP
Capitalization273M3.52M7,756%
EBITDA-175.87M-7.09M2,479%
Gain YTD-21.68914.411-151%
P/E RatioN/AN/A-
Revenue1.28M0-
Total Cash190M4.09M4,643%
Total Debt3.58M0-
FUNDAMENTALS RATINGS
CDTX vs TTNP: Fundamental Ratings
CDTX
TTNP
OUTLOOK RATING
1..100
2124
VALUATION
overvalued / fair valued / undervalued
1..100
51
Fair valued
100
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9898
PRICE GROWTH RATING
1..100
3960
P/E GROWTH RATING
1..100
10073
SEASONALITY SCORE
1..100
8565

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CDTX's Valuation (51) in the Biotechnology industry is somewhat better than the same rating for TTNP (100) in the Pharmaceuticals Major industry. This means that CDTX’s stock grew somewhat faster than TTNP’s over the last 12 months.

CDTX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as TTNP (100) in the Pharmaceuticals Major industry. This means that CDTX’s stock grew similarly to TTNP’s over the last 12 months.

CDTX's SMR Rating (98) in the Biotechnology industry is in the same range as TTNP (98) in the Pharmaceuticals Major industry. This means that CDTX’s stock grew similarly to TTNP’s over the last 12 months.

CDTX's Price Growth Rating (39) in the Biotechnology industry is in the same range as TTNP (60) in the Pharmaceuticals Major industry. This means that CDTX’s stock grew similarly to TTNP’s over the last 12 months.

TTNP's P/E Growth Rating (73) in the Pharmaceuticals Major industry is in the same range as CDTX (100) in the Biotechnology industry. This means that TTNP’s stock grew similarly to CDTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CDTXTTNP
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 10 days ago
85%
Bullish Trend 8 days ago
79%
Declines
ODDS (%)
Bearish Trend 29 days ago
90%
Bearish Trend 25 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
81%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
N/A
View a ticker or compare two or three
Ad is loading...
CDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TTNP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ITHTX50.45N/A
N/A
Hartford Capital Appreciation R5
IVRSX27.62N/A
N/A
VY® CBRE Real Estate S
SPMCX7.00N/A
N/A
Saratoga Mid Capitalization C
IPETX5.88N/A
N/A
Voya Large Cap Value Port S2
ASILX14.79N/A
N/A
AB Select US Long/Short I

CDTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CDTX has been closely correlated with BPTSY. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if CDTX jumps, then BPTSY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CDTX
1D Price
Change %
CDTX100%
-0.33%
BPTSY - CDTX
92%
Closely correlated
-42.26%
IVVD - CDTX
36%
Loosely correlated
-0.82%
CPRX - CDTX
35%
Loosely correlated
N/A
REPL - CDTX
34%
Loosely correlated
+4.05%
CABA - CDTX
33%
Poorly correlated
+2.73%
More

TTNP and

Correlation & Price change

A.I.dvisor indicates that over the last year, TTNP has been loosely correlated with INM. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if TTNP jumps, then INM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TTNP
1D Price
Change %
TTNP100%
+3.89%
INM - TTNP
49%
Loosely correlated
-1.16%
ORMP - TTNP
28%
Poorly correlated
-0.43%
SPHRY - TTNP
27%
Poorly correlated
N/A
CDTX - TTNP
27%
Poorly correlated
-0.33%
SER - TTNP
26%
Poorly correlated
+9.17%
More